Cancer Vaccines in Ovarian Cancer: How Can We Improve?

by Silvia Martin Lluesma, Anita Wolfer, Alexandre Harari, Lana E. Kandalaft
Published 2016-05-01

Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

by Silvia Martin Lluesma, Michele Graciotti, Cheryl Lai-Lai Chiang, Lana E. Kandalaft
Published 2018-11-01

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity

by Pelagia G. Tsoutsou, Pelagia G. Tsoutsou, Pelagia G. Tsoutsou, Khalil Zaman, Silvia Martin Lluesma, Laurene Cagnon, Lana Kandalaft, Marie-Catherine Vozenin
Published 2018-12-01

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancre...

by Michal Bassani-Sternberg, Michal Bassani-Sternberg, Antonia Digklia, Florian Huber, Florian Huber, Dorothea Wagner, Christine Sempoux, Brian J. Stevenson, Anne-Christine Thierry, Justine Michaux, Justine Michaux, HuiSong Pak, HuiSong Pak, Julien Racle, Julien Racle, Caroline Boudousquie, Klara Balint, Klara Balint, George Coukos, George Coukos, David Gfeller, David Gfeller, Silvia Martin Lluesma, Silvia Martin Lluesma, Alexandre Harari, Alexandre Harari, Nicolas Demartines, Lana E. Kandalaft, Lana E. Kandalaft
Published 2019-08-01

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade o...

by Apostolos Sarivalasis, Caroline Boudousquié, Klara Balint, Brian J. Stevenson, Philippe O. Gannon, Emanuela Marina Iancu, Laetitia Rossier, Silvia Martin Lluesma, Patrice Mathevet, Christine Sempoux, George Coukos, Urania Dafni, Alexandre Harari, Michal Bassani-Sternberg, Lana E. Kandalaft
Published 2019-11-01